Published in Osteoporos Int on April 16, 2011
Increased risk of dementia in patients with osteoporosis: a population-based retrospective cohort analysis. Age (Dordr) (2013) 0.88
Challenges in implementing and maintaining osteoporosis therapy. Int J Womens Health (2014) 0.86
Diagnosis and treatment of osteoporosis in high-risk patients prior to hip fracture. Geriatr Orthop Surg Rehabil (2012) 0.82
Inappropriate Drug Use in People with Cognitive Impairment and Dementia: A Systematic Review. Curr Clin Pharmacol (2015) 0.79
Educational level and use of osteoporosis drugs in elderly men and women: a Swedish nationwide register-based study. Osteoporos Int (2012) 0.78
Factors associated with medication regimen complexity in older people: a cross-sectional population-based study. Eur J Clin Pharmacol (2015) 0.78
Fracture prevention in patients with cognitive impairment presenting with a hip fracture: secondary analysis of data from the HORIZON Recurrent Fracture Trial. Osteoporos Int (2013) 0.77
Incidence and Duration of Cumulative Bisphosphonate Use among Community-Dwelling Persons with or without Alzheimer's Disease. J Alzheimers Dis (2016) 0.75
Examining the treatment gap and risk of subsequent fractures among females with a fragility fracture in the US Medicare population. Osteoporos Int (2017) 0.75
Dementia and osteoporosis in a geriatric population: Is there a common link? World J Orthop (2017) 0.75
"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res (1975) 301.74
Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med (1992) 9.86
Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. N Engl J Med (2001) 9.57
Falls, injuries due to falls, and the risk of admission to a nursing home. N Engl J Med (1997) 6.18
Osteoporosis. Lancet (2006) 5.40
European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int (2008) 5.27
Epidemiology of osteoporotic fractures. Osteoporos Int (2004) 3.60
Epidemiology of falls. Age Ageing (2001) 3.22
Alendronate for the treatment of osteoporosis in men. N Engl J Med (2000) 3.11
The burden of osteoporotic fractures: a method for setting intervention thresholds. Osteoporos Int (2001) 2.81
Meta-analyses of therapies for postmenopausal osteoporosis. II. Meta-analysis of alendronate for the treatment of postmenopausal women. Endocr Rev (2002) 2.49
Missed opportunities for osteoporosis treatment in patients hospitalized for hip fracture. J Am Geriatr Soc (2010) 2.32
Vitamin D and calcium supplementation prevents osteoporotic fractures in elderly community dwelling residents: a pragmatic population-based 3-year intervention study. J Bone Miner Res (2003) 2.15
Costs and quality of life associated with osteoporosis-related fractures in Sweden. Osteoporos Int (2005) 2.05
Vitamin D concentrations among people aged 65 years and over living in private households and institutions in England: population survey. Age Ageing (2005) 1.81
A longitudinal study integrating population, care and social services data. The Swedish National study on Aging and Care (SNAC). Aging Clin Exp Res (2004) 1.78
Epidemiology, treatment and costs of osteoporosis in Germany--the BoneEVA Study. Osteoporos Int (2006) 1.75
Differing patterns of antiresorptive pharmacotherapy in nursing facility residents and community dwellers. J Am Geriatr Soc (2005) 1.71
Treating nondementia illnesses in patients with dementia. JAMA (2000) 1.66
Low bone mass and postfall fracture risk among elderly nursing home men. J Am Med Dir Assoc (2004) 1.61
The prevalence of osteoporosis in nursing home residents. Osteoporos Int (1999) 1.59
The risk factors of fall and their correlation with balance, depression, cognitive impairment and mobility skills in elderly nursing home residents. Saudi Med J (2005) 1.59
Risedronate therapy for prevention of hip fracture after stroke in elderly women. Neurology (2005) 1.55
Occurrence of dementia in advanced age: the study design of the Kungsholmen Project. Neuroepidemiology (1992) 1.54
Retracted Risedronate sodium therapy for prevention of hip fracture in men 65 years or older after stroke. Arch Intern Med (2005) 1.53
Meta-analyses of therapies for postmenopausal osteoporosis. III. Meta-analysis of risedronate for the treatment of postmenopausal osteoporosis. Endocr Rev (2002) 1.44
The near absence of osteoporosis treatment in older men with fractures. Osteoporos Int (2005) 1.35
Low incidence of anti-osteoporosis treatment after hip fracture. J Bone Joint Surg Am (2008) 1.27
Hip fractures and Alzheimer's disease in elderly institutionalized Canadians. Ann Epidemiol (2004) 1.22
Hip and other osteoporotic fractures increase the risk of subsequent fractures in nursing home residents. Osteoporos Int (2008) 1.11
Mortality, morbidity, and assessment of fracture risk in male osteoporosis. Calcif Tissue Int (2001) 1.10
Aspirin, NSAIDs, risk of dementia, and influence of the apolipoprotein E epsilon 4 allele in an elderly population. Neuroepidemiology (2004) 1.09
Osteoporosis management among residents living in long-term care. Osteoporos Int (2009) 1.07
Underuse of procedures for diagnosing osteoporosis and of therapies for osteoporosis in older nursing home residents. J Am Med Dir Assoc (2003) 1.04
Incidence of injury-causing falls among older adults by place of residence: a population-based study. J Am Geriatr Soc (1995) 1.01
Use of osteoporosis medications in older nursing facility residents. J Am Med Dir Assoc (2007) 1.00
Undertreatment of osteoporosis in the oldest old? A nationwide study of over 700,000 older people. Arch Osteoporos (2009) 0.90
Integrating a gender dimension into osteoporosis and fracture risk research. Gend Med (2007) 0.90
Factors associated with pharmacologic treatment of osteoporosis in an older home care population. J Gerontol A Biol Sci Med Sci (2007) 0.90
Falls in the nursing home: are they preventable? J Am Med Dir Assoc (2006) 0.87
Development of a simple prognostic nomogram for individualising 5-year and 10-year absolute risks of fracture: a population-based prospective study among postmenopausal women. Ann Rheum Dis (2010) 0.82
Musculoskeletal pain and analgesic therapy in a very old population. Arch Gerontol Geriatr (2004) 0.82
Underutilization of antiosteoporotic drugs by orthopedic surgeons for prevention of a secondary osteoporotic fracture. J Orthop Sci (2006) 0.81
Prescription of anti-osteoporosis drugs during 2004-2007-a nationwide register study in Norway. Eur J Clin Pharmacol (2009) 0.80
The use of angiotensin-converting enzyme inhibitors and other drugs with cardiovascular effects by non-demented and demented elderly with a clinical diagnosis of heart failure. A population-based study of the very old. Eur J Clin Pharmacol (2006) 0.79
Drug use by demented and non-demented elderly people. Age Ageing (1997) 0.78
Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med (2004) 16.58
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46
The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol (2011) 9.40
Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology (2000) 3.39
Predictors of progression from mild cognitive impairment to Alzheimer disease. Neurology (2007) 2.72
Head trauma as a risk factor for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. Int J Epidemiol (1991) 2.63
Prevalence of Parkinson's disease in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology (2000) 2.45
The course of cognitive impairment in preclinical Alzheimer disease: three- and 6-year follow-up of a population-based sample. Arch Neurol (2000) 2.37
Alcohol and tobacco consumption as risk factors for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. Int J Epidemiol (1991) 2.36
The appropriateness of drug use in an older nondemented and demented population. J Am Geriatr Soc (2001) 2.30
Low blood pressure and dementia in elderly people: the Kungsholmen project. BMJ (1996) 2.20
Diabetes mellitus and risk of dementia in the Kungsholmen project: a 6-year follow-up study. Neurology (2004) 2.10
Vitamin B(12) and folate in relation to the development of Alzheimer's disease. Neurology (2001) 2.04
Midlife overweight and obesity increase late-life dementia risk: a population-based twin study. Neurology (2011) 1.84
Stability of the preclinical episodic memory deficit in Alzheimer's disease. Brain (2001) 1.83
Prognosis with dementia in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology (2000) 1.76
The occurrence of depressive symptoms in the preclinical phase of AD: a population-based study. Neurology (1999) 1.67
Mild cognitive impairment: a concept in evolution. J Intern Med (2014) 1.65
The impact of chronic multimorbidity and disability on functional decline and survival in elderly persons. A community-based, longitudinal study. J Intern Med (2009) 1.57
Institutionalization in the elderly: the role of chronic diseases and dementia. Cross-sectional and longitudinal data from a population-based study. J Clin Epidemiol (2001) 1.54
Dementia is the major cause of functional dependence in the elderly: 3-year follow-up data from a population-based study. Am J Public Health (1998) 1.51
Aging and the occurrence of dementia: findings from a population-based cohort with a large sample of nonagenarians. Arch Neurol (1999) 1.50
Risk factors for clinically diagnosed Alzheimer's disease: a case-control study of an Italian population. Neurology (1986) 1.48
Intrathecal synthesis of free immunoglobulin light chains and IgM in initial multiple sclerosis. Acta Neurol Scand (1991) 1.46
The influence of education on clinically diagnosed dementia incidence and mortality data from the Kungsholmen Project. Arch Neurol (2001) 1.38
Mortality from dementia in advanced age: a 5-year follow-up study of incident dementia cases. J Clin Epidemiol (1999) 1.38
Levels of alpha- and beta-secretase cleaved amyloid precursor protein in the cerebrospinal fluid of Alzheimer's disease patients. Neurosci Lett (2000) 1.37
Trends in polypharmacy and potential drug-drug interactions across educational groups in elderly patients in Sweden for the period 1992 - 2002. Int J Clin Pharmacol Ther (2007) 1.34
Psychiatric history and related exposures as risk factors for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. Int J Epidemiol (1991) 1.33
Uncontrolled diabetes increases the risk of Alzheimer's disease: a population-based cohort study. Diabetologia (2009) 1.29
Accuracy of the Mini-Mental Status Examination as a screening test for dementia in a Swedish elderly population. Acta Neurol Scand (1993) 1.25
Risk and protective effects of the APOE gene towards Alzheimer's disease in the Kungsholmen project: variation by age and sex. J Neurol Neurosurg Psychiatry (2004) 1.25
Occurrence of cognitive impairment and dementia in the community: a 9-year-long prospective study. Neurology (2008) 1.24
Smoking and the occurrence of Alzheimer's disease: cross-sectional and longitudinal data in a population-based study. Am J Epidemiol (1999) 1.24
Advances in the prevention of Alzheimer's disease and dementia. J Intern Med (2014) 1.23
Occurrence and progression of dementia in a community population aged 75 years and older: relationship of antihypertensive medication use. Arch Neurol (1999) 1.23
Alterations in the ryanodine receptor calcium release channel correlate with Alzheimer's disease neurofibrillary and beta-amyloid pathologies. Neuroscience (1999) 1.23
Psychotropic drug use in elderly people with and without dementia. Int J Geriatr Psychiatry (2001) 1.23
Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer's disease. Mol Psychiatry (2012) 1.20
Familial aggregation of Alzheimer's disease and related disorders: a collaborative re-analysis of case-control studies. Int J Epidemiol (1991) 1.20
Cognitive impairment, drug use, and the risk of hip fracture in persons over 75 years old: a community-based prospective study. Am J Epidemiol (1998) 1.18
Prognostic factors in very old demented adults: a seven-year follow-up from a population-based survey in Stockholm. J Am Geriatr Soc (1998) 1.17
Incidence of stroke in young adults in Florence, Italy. Stroke (1988) 1.16
Interrater reliability in assessing functional systems and disability on the Kurtzke scale in multiple sclerosis. Arch Neurol (1988) 1.15
Blood pressure and performance on the Mini-Mental State Examination in the very old. Cross-sectional and longitudinal data from the Kungsholmen Project. Am J Epidemiol (1997) 1.13
Personality and lifestyle in relation to dementia incidence. Neurology (2009) 1.12
Natural history of Alzheimer's disease and other dementias: review of the literature in the light of the findings from the Kungsholmen Project. Int J Geriatr Psychiatry (1998) 1.10
APOE and cognitive decline in preclinical Alzheimer disease and non-demented aging. Neurology (2004) 1.10
Aspirin, NSAIDs, risk of dementia, and influence of the apolipoprotein E epsilon 4 allele in an elderly population. Neuroepidemiology (2004) 1.09
Lack of association between apolipoprotein E allele epsilon 4 and sporadic Alzheimer's disease. Neurosci Lett (1994) 1.06
Mortality in nondemented subjects with cognitive impairment: the influence of health-related factors. Am J Epidemiol (1999) 1.05
Interaction between genetic and environmental risk factors for Alzheimer's disease: a reanalysis of case-control studies. Genet Epidemiol (1994) 1.05
Medical history and the risk of Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. Int J Epidemiol (1991) 1.04
The role of APOE polymorphisms in late-onset dementias. Cell Mol Life Sci (1998) 1.03
Homocysteine and holo-transcobalamin and the risk of dementia and Alzheimers disease: a prospective study. Eur J Neurol (2009) 1.03
The effect of education on dementia occurrence in an Italian population with middle to high socioeconomic status. Neurology (1998) 1.00
Low blood pressure and incidence of dementia in a very old sample: dependent on initial cognition. J Am Geriatr Soc (1999) 0.99
Mild cognitive impairment in the population and physical health: data on 1,435 individuals aged 75 to 95. J Gerontol A Biol Sci Med Sci (2000) 0.99
Canaries in a coal mine: cognitive markers of preclinical Alzheimer disease. Arch Gen Psychiatry (2001) 0.98
Cognitive predictors of incident Alzheimer's disease: a prospective longitudinal study. Neuropsychology (1997) 0.97
Occupational exposures to solvents and lead as risk factors for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. Int J Epidemiol (1991) 0.96
Apolipoprotein E genotypes and the incidence of Alzheimer's disease among persons aged 75 years and older: variation by use of antihypertensive medication? Am J Epidemiol (2001) 0.96
Incidence of stroke in relation to cognitive function and dementia in the Kungsholmen Project. Neurology (2000) 0.96
Memory complaints of elderly people in a population survey: variation according to dementia stage and depression. J Am Geriatr Soc (1993) 0.95
Clinical staging of dementia in a population survey: comparison of DSM-III-R and the Washington University Clinical Dementia Rating Scale. Acta Psychiatr Scand (1992) 0.94
Role of G proteins, cyclic AMP, and ion channels in the inhibition of transmitter release by adenosine. Ann N Y Acad Sci (1990) 0.94
Ischaemic damage in gerbil hippocampus is reduced following upregulation of adenosine (A1) receptors by caffeine treatment. Neurosci Lett (1989) 0.93
Association of stroke with dementia, cognitive impairment, and functional disability in the very old: a population-based study. Stroke (1998) 0.93
Inhibition of [3H] glutamate release from rat hippocampal slices by L-phenylisopropyladenosine. Acta Physiol Scand (1985) 0.93
Protective effect of adenosine and a novel xanthine derivative propentofylline on the cell damage after bilateral carotid occlusion in the gerbil hippocampus. Brain Res (1990) 0.92
Cognitive support at episodic encoding and retrieval: similar patterns of utilization in community-based samples of Alzheimer's disease and vascular dementia patients. J Clin Exp Neuropsychol (1999) 0.92
Attitudes and participation of the elderly in population surveys: data from a longitudinal study on aging and dementia in Stockholm. J Clin Epidemiol (1998) 0.91
Incidence of dementia in relation to stroke and the apolipoprotein E epsilon4 allele in the very old. Findings from a population-based longitudinal study. Stroke (2000) 0.91
Cognitive performance in very old diabetic persons: the impact of semantic structure, preclinical dementia, and impending death. Neuropsychology (2002) 0.90
Tau gene polymorphisms and apolipoprotein E epsilon4 may interact to increase risk for Alzheimer's disease. Neurosci Lett (1999) 0.90
Health and social consequences for relatives of demented and non-demented elderly. A population-based study. J Clin Epidemiol (1992) 0.90
Frequency of stroke in Europe: A collaborative study of population-based cohorts. ILSA Working Group and the Neurologic Diseases in the Elderly Research Group. Italian Longitudinal Study on Aging. Neurology (2000) 0.89
Determinants of functional abilities in dementia. J Am Geriatr Soc (1995) 0.88
Lead concentrations in elderly urban people related to blood pressure and mental performance: results from a population-based study. Am J Ind Med (2000) 0.88
Morbidity and comorbidity in relation to functional status: a community-based study of the oldest old (90+ years). J Am Geriatr Soc (2000) 0.88
Maternal age and Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. Int J Epidemiol (1991) 0.88
Medial temporal lobe is vulnerable to vascular risk factors in men: a population-based study. Eur J Neurol (2012) 0.87
Blood pressure reduction, cardiovascular diseases, and cognitive decline in the mini-mental state examination in a community population of normal very old people: a three-year follow-up. J Clin Epidemiol (1998) 0.86
Lifestyle factors related to mortality and survival: a mini-review. Gerontology (2014) 0.86
IAGG workshop: health promotion program on prevention of late onset dementia. J Nutr Health Aging (2011) 0.86
The symptom of low mood in the prodromal stage of mild cognitive impairment and dementia: a cohort study of a community dwelling elderly population. J Neurol Neurosurg Psychiatry (2011) 0.85
Cobalamin levels are not reduced in Alzheimer's disease: results from a population-based study. J Am Geriatr Soc (1994) 0.83
Epidemiological studies of cognitive impairment and dementia across Eastern and Middle European countries (epidemiology of dementia in Eastern and Middle European Countries). Int J Geriatr Psychiatry (2011) 0.83
Visualization of adenosine A1 receptors in the human and the guinea-pig kidney. Eur J Pharmacol (1987) 0.83
Application of DSM-III-R criteria for major depressive episode to elderly subjects with and without dementia. Am J Psychiatry (1993) 0.83
Episodic memory and visuospatial ability in detecting and staging dementia in a community-based sample of very old adults. J Gerontol A Biol Sci Med Sci (1995) 0.83
Prognosis with Parkinson's disease in europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology (2000) 0.83
Predictors of cognitive change from preclinical to clinical Alzheimer's disease. Brain Cogn (2002) 0.83
The influence of vascular disease on cognitive performance in the preclinical and early phases of Alzheimer's disease. Dement Geriatr Cogn Disord (2010) 0.83